Talcid

Talcid is an over-the-counter gastrointestinal-medicine brand whose principal active ingredient is hydrotalcite, an aluminium-magnesium compound used to neutralize stomach acid. In China, the brand is widely known by the name 达喜 and is positioned for short-term relief of symptoms associated with excess gastric acid, including heartburn, acid indigestion and related dyspeptic discomfort. The product is generally supplied as chewable tablets, allowing it to be taken without water and making it suitable for use after meals or when symptoms occur. The brand is associated with Bayer's consumer-health portfolio. Bayer is a German life-sciences company with businesses in pharmaceuticals, consumer health and crop science; Talcid belongs to the consumer-health area rather than to Bayer's prescription-medicine portfolio. Publicly available product information identifies hydrotalcite as the characteristic ingredient and describes the medicine as an antacid rather than as a treatment that suppresses acid production through proton-pump inhibition or histamine-2 blockade. This distinction is important to the product's positioning: Talcid is intended primarily for symptomatic neutralization of acid already present in the stomach. In China, 达喜 has been marketed through pharmacies, medical institutions and consumer-health channels. Its brand communication has typically emphasized stomach comfort, acid neutralization and convenience of use. The Chinese-market product should not automatically be treated as identical in every detail to products sold under the Talcid name elsewhere, because dosage forms, package sizes, approved indications and regulatory labeling may vary by jurisdiction. The brand's precise origin date, original developer and detailed international ownership history are not established here from a sufficiently reliable source. Bayer's corporate ownership and current Chinese-market association are better documented than the early history of the trademark. No reliable evidence was supplied for a separate Chinese corporate headquarters, an independent public listing, or a distinct founder. Talcid should therefore be understood as an international consumer-health product brand rather than as a standalone Chinese company. As an OTC medicine, Talcid remains subject to local rules governing indications, labeling, advertising, pharmacovigilance and dispensing. Consumers are generally advised to follow the package insert and seek medical advice for persistent, severe or recurrent symptoms, because acid-related discomfort can have causes requiring professional diagnosis. The brand's continuing relevance rests on its recognizable name, established hydrotalcite formulation and presence in the antacid segment.

Talcid is an antacid brand associated with hydrotalcite, an aluminium-magnesium compound used to neutralize gastric acid. The product is supplied primarily as a chewable oral medicine and has been used for symptomatic relief of heartburn, acid indigestion and other acid-related upper-gastrointestinal complaints. The brand is connected with Bayer's consumer-health business and is marketed in China under the Chinese name 达喜. In the Chinese market, the product is commonly identified as an aluminium hydrotalcite or aluminium-magnesium carbonate chewable tablet, although regulatory descriptions and exact formulation details should be checked against the current local package insert. The Chinese brand has achieved broad recognition through pharmacy distribution and consumer-health advertising, making 达喜 one of the more visible antacid names in the market. Talcid's therapeutic role differs from that of medicines that reduce acid production over a longer period. Hydrotalcite acts locally in the stomach by binding or neutralizing acid, so the product is positioned mainly for symptomatic use. Packaging, approved indications, dosage instructions and legal status can differ between countries, and the Chinese product should be evaluated according to Chinese regulatory labeling rather than assumptions based on overseas versions. Available reference material does not establish a definitive founding year for the brand or provide a sufficiently documented account of its original inventor or developer. It is therefore more accurate to describe Talcid through its formulation, therapeutic category and Bayer consumer-health association than to assign it an unsupported origin date. Likewise, Talcid is a product brand and not an independently listed corporation. Bayer AG is the relevant corporate group, while the brand's local commercial and regulatory arrangements may vary by market and by period. The brand operates within a regulated OTC-medicine environment. Its communications and packaging must address safe use, dosage, contraindications, interactions and the need for medical consultation when symptoms persist. Long-lasting or severe reflux, abdominal pain, vomiting, bleeding or unexplained weight loss can require clinical assessment rather than repeated self-medication. Talcid's continuing market role is consequently based on its established name, chewable format and hydrotalcite-based antacid positioning.

1. Hydrotalcite antacid brand established

   Talcid was established as a consumer antacid brand based on hydrotalcite. A reliable public source for the exact launch year was not identified.
2. Expansion in China under the 达喜 name

   The brand became established in China as 达喜 and was distributed as a chewable OTC antacid for acid-related stomach discomfort. The exact market-entry year is not confirmed here.

A familiar OTC antacid brand focused on rapid, convenient neutralization of excess stomach acid and relief of heartburn or acid-indigestion symptoms.

• Talcid chewable tabletsOTC antacid

  The core Talcid offering is a chewable hydrotalcite-based antacid. It is intended to neutralize excess gastric acid and provide symptomatic relief for complaints such as heartburn and acid indigestion. The chewable format is designed for convenient administration without water. Exact strength, dosage, pack size, approved indications and age restrictions depend on the market and should be verified against the applicable product information.

• 达喜铝碳酸镁咀嚼片Chinese-market OTC antacid

  The Chinese-market product sold as 达喜 is commonly described as an aluminium-magnesium carbonate or hydrotalcite chewable tablet. It is positioned for relief of excess-acid symptoms and related upper-gastrointestinal discomfort. Because Chinese registration details and labeling may change, the current package insert remains the authoritative source for composition, indications, dosage and warnings.